Howard Lawrence Golub - 06 Jun 2023 Form 3 Insider Report for Organicell Regenerative Medicine, Inc. (ZEOX)

Role
Executive Vice President & CSO
Signature
/s/ Howard Golub
Issuer symbol
ZEOX
Transactions as of
06 Jun 2023
Net transactions value
$0
Form type
3
Filing time
09 Jun 2023, 16:35:32 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OCEL Options to Purchase Common Stock 06 Jun 2023 Common Stock, par value $0.001 per share 50,000,000 $0.0120 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an option to purchase common stock granted to the Reporting Person on June 6, 2023 under the issuer's Equity Incentive Plan (the "Plan"). The option vests in equal quarterly installments over a one-year period from the date of grant, is contingent upon the Reporting Person's continued employment by the issuer and is otherwise subject to the terms and conditions of the Plan.